| 2/25/2025 | BKIG | Moody's sees Akzo Nobel negatively
|
| 11/13/2024 | BKIG | S&P views Akzo Nobel negatively
|
| 2/17/2023 | BKIG | Moody's downgrades Akzo Nobel
|
| 11/22/2022 | BKIG | S&P trims Akzo Nobel
|
| 10/11/2022 | BKIG | Moody's changes AkzoNobel view to negative
|
| 11/30/2020 | BKHYIG | Fitch revises Akzo Nobel view to stable
|
| 10/11/2018 | HY | Market Commentary: Morning Commentary: Buyers lift junk ˝ point Thursday morning; fund flows moderate
|
| 10/2/2018 | BKIG | S&P lowers Akzo Nobel
|
| 9/24/2018 | BKCVDDEMIGPV | Market Commentary: Tallgrass prices; Envision’s $1.625 billion offering on tap; Refinitiv weakens
|
| 9/24/2018 | HY | Market Commentary: Tallgrass prices; Envision’s $1.625 billion offering on tap; Refinitiv weakens; energy names gain
|
| 9/20/2018 | BKCVDDEMIGPV | Market Commentary: AkzoNobel prices; Refinitiv mixed again; CalRes declines; L Brands, Neiman Marcus rise
|
| 9/20/2018 | HY | Market Commentary: AkzoNobel prices €1 billion; Refinitiv mixed again; CalRes declines; L Brands, Neiman Marcus rise
|
| 9/20/2018 | HY | New Issue: AkzoNobel prices downsized €1 billion equivalent eight-year notes in two tranches
|
| 9/20/2018 | HY | AkzoNobel launches €485 million eight-year notes to yield 6˝%; pricing Thursday
|
| 9/19/2018 | HY | Market Commentary: AkzoNobel downsizes deal; Refinitiv busy; Diamondback gains; Neiman Marcus mixed
|
| 9/19/2018 | BKCVDDEMIGPV | Market Commentary: AkzoNobel downsizes deal; Refinitiv busy; Diamondback gains; Neiman Marcus mixed
|
| 9/19/2018 | CLHY | Market Commentary: As pricing tightens, AkzoNobel's upsized dollar loan playing to $10 billion book
|
| 9/19/2018 | BK | Market Commentary: As pricing tightens, AkzoNobel's upsized dollar loan playing to $10 billion book
|
| 9/19/2018 | BKHY | AkzoNobel tweaks bonds and loans backing Carlyle's buyout; pricing set for Thursday
|
| 9/14/2018 | BKCVDDEMIGPV | Market Commentary: Schweitzer-Mauduit, Carvana, Enova, Fortress price; Refinitiv, AkzoNobel on tap; AMC down
|
| 9/14/2018 | HY | Market Commentary: Schweitzer-Mauduit, Carvana, Enova, Fortress price; Refinitiv, AkzoNobel on tap; AMC down
|
| 9/7/2018 | HY | Market Commentary: AkzoNobel sets roadshow; Eldorado trades up; Cheniere, Avolon unchanged; Tesla’s new low
|
| 9/7/2018 | BKCVDDEMIGPV | Market Commentary: AkzoNobel sets roadshow; Eldorado trades up; Cheniere, Avolon unchanged; Tesla’s new low
|
| 9/7/2018 | HY | Market Commentary: Morning Commentary: AkzoNobel kicks off €1.39 billion offering; ETFs see big outflows
|
| 9/7/2018 | HY | AkzoNobel to start roadshow Monday for €1.39 billion eight-year notes in dollars and euros
|
| 8/24/2018 | HY | Market Commentary: September deals eyed; energy sector gains; Rackspace drops; Avantor active
|
| 8/24/2018 | BKCVDDEMIGPV | Market Commentary: September deals eyed; energy sector gains; Rackspace drops; Avantor active
|
| 8/24/2018 | HY | Market Commentary: Morning Commentary: Energy bonds steady as crude oil rallies; ETFs see Thursday outflow
|
| 8/21/2018 | HY | AkzoNobel spinoff to generate around €1.5 billion equivalent bonds expected in September
|
| 4/25/2018 | BKIG | Fitch gives Akzo Nobel negative outlook
|
| 10/20/2017 | BKIG | S&P affirms Akzo Nobel
|
| 5/5/2017 | BKIG | S&P cuts Akzo short-term, puts on review
|
| 10/21/2016 | BKIG | S&P upgrades Akzo, loan, notes to A-
|
| 10/23/2012 | IG | Moody's could cut Akzo Nobel
|
| 11/19/2007 | SS | Schering-Plough expands into two Rx franchises with acquisition of Organon
|
| 3/12/2007 | SS | Market Commentary: New Century demise imminent; Ocwen off; Gateway, Openwave higher; Tribune trips; Cortex rises
|
| 7/18/2006 | BT | FDA approves Implanon, a three-year implantable contraceptive
|
| 2/7/2006 | BT | S&P's Akzo Nobel ratings unaffected
|
| 2/7/2006 | BT | Fitch downs Akzo Nobel outlook to negative
|
| 2/7/2006 | BT | Moody's affirms Akzo Nobel
|
